Flexible Solutions International, Inc. (FSI) has been upgraded to Speculative Buy due to strong progress in its food-grade chemical production and the ramp-up of major contracts. While the company faces short-term profitability challenges from scaling up food production, management expects profitability to return in Q3 and earnings to accelerate in Q4. Key food contracts guarantee at least $6.5 million in annual revenue, with a target of over $50 million combined and projected gross margins of 22–25%. Although current stock valuation seems high, successful execution and increased volumes could significantly improve profitability and valuation by 2027.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...
SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...
Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...
Citigroup reaffirmed its Buy rating on NIO but lowered the price target from $8.20 to $7.10 due to NIO's second-quarter deliveries and revenue missing company guidance and a third-quarter outlook below Wall Street estimates. Despite a 49.4% year-over...
